Effect of CAG repeat length on psychiatric disorders in Huntington's disease

Journal of Psychiatric Research

Volumn 42, Issue 7, 2008, Pages 544-549

  Vassos, Evangelos ^a   Panas, Marios ^a   Kladi, Athina ^a   Vassilopoulos, Dimitrios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

CAG repeats; Genetics; Huntington disease; Neuropsychiatry; Psychiatric disorders; SCID

Indexed keywords

TRINUCLEOTIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE PHENOTYPE CORRELATION; GREECE; HEREDITY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NUCLEOTIDE REPEAT; ONSET AGE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; TRINUCLEOTIDE REPEAT;

ANXIETY DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA REPEAT EXPANSION; FEMALE; GENOTYPE; HUMANS; HUNTINGTON DISEASE; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MOOD DISORDERS; PHENOTYPE; PREVALENCE; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEATS;

EID: 40849104805     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.05.008     Document Type: Article

References (37)

1. Anderson K.E., and Marder K.S. An overview of psychiatric symptoms in Huntington's disease. Current Psychiatry Reports 3 (2001) 379-388
2. Andrew S.E., Goldberg Y.P., Kremer B., Telenius H., Theilmann J., Adam S., et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics 4 (1993) 398-403
3. Berrios G.E., Wagle A.C., Markova I.S., Wagle S.A., Ho L.W., Rubinsztein D.C., et al. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Research 102 (2001) 217-225
4. Brandt J., Bylsma F.W., Gross R., Stine O.C., Ranen N., and Ross C.A. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46 (1996) 527-531
5. Brinkman R.R., Mezei M.M., Theilmann J., Almqvist E., and Hayden M.R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. American Journal of Human Genetics 60 (1997) 1202-1210
6. Caine T.M., Foulds G.A., and Hope K. Manual of the hostility and direction of hostility questionnaire. Personality and personal illness questionnaires (1967), University of London Press, London
7. Claes S., Van Zand K., Legius E., Dom R., Malfroid M., Baro F., et al. Correlations between triplet repeat expansion and clinical features in Huntington's disease. Archives of Neurology 52 (1995) 749-753
8. Craufurd D., Thompson J.C., and Snowden J.S. Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychology and Behavioral Neurology 14 (2001) 219-226
9. Derogatis L. Administration, scoring and procedures for the R(evised) version (1977), John Hopkins University School of Medicine, Baltimore
10. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genetics 4 (1993) 387-392
11. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured clinical interview for DSM-IV axis I disorders - patient edition with psychotic screen (1996), Biometrics Research Department, New York State Psychiatric Institute, New York
12. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12 (1975) 189-198
13. Folstein S.E., Leigh R.J., Parhad I.M., and Folstein M.F. The diagnosis of Huntington's disease. Neurology 36 (1986) 1279-1283
14. Furtado S., Suchowersky O., Rewcastle B., Graham L., Klimek M.L., and Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Annals of Neurology 39 (1996) 132-136
15. Illarioshkin S.N., Igarashi S., Onodera O., Markova E.D., Nikolskaya N.N., Tanaka H., et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Annals of Neurology 36 (1994) 630-635
16. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., and Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 65 (2004) 267-277
17. MacMillan J.C., Snell R.G., Tyler A., Houlihan G.D., Fenton I., Cheadle J.P., et al. Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 342 (1993) 954-958
18. Madianos M.G., Economou M., and Stefanis C.N. Long-term outcome of psychiatric disorders in the community: a 13-year follow-up study in a nonclinical population. Comprehensive Psychiatry 39 (1998) 47-56
19. Mahant N., McCusker E.A., Byth K., and Graham S. Huntington's disease: clinical correlates of disability and progression. Neurology 61 (2003) 1085-1092
20. Margolis R.L., and Ross C.A. Diagnosis of Huntington disease. Clinical Chemistry 49 (2003) 1726-1732
21. Mavreas V.G., Beis A., Mouyias A., Rigoni F., and Lyketsos G.C. Prevalence of psychiatric disorders in Athens: a community study. Social Psychiatry 21 (1986) 172-181
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1998) 1215
23. Naarding P., Kremer H.P., and Zitman F.G. Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena. European Psychiatry 16 (2001) 439-445
24. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., and Cummings J.L. Neuropsychiatric aspects of Huntington's disease. Journal of Neurology Neurosurgery and Psychiatry 71 (2001) 310-314
25. Penney Jr. J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., and Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 41 (1997) 689-692
26. Rachman S., and Hodgson R.J. Obsessions and compulsions (1980), Prentice-Hall, Englewood Cliffs
27. Rosenblatt A., Liang K.Y., Zhou H., Abbott M.H., Gourley L.M., Margolis R.L., et al. The association of CAG repeat length with clinical progression in Huntington disease. Neurology 66 (2006) 1016-1020
28. Rubinsztein D.C., Leggo J., Chiano M., Dodge A., Norbury G., Rosser E., et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proceedings of the National Academy of Science of theUnited States of America 94 (1997) 3872-3876
29. Snaith R.P., Constantopoulos A.A., Jardine M.Y., and McGuffin P. A clinical scale for the self-assessment of irritability. British Journal of Psychiatry 132 (1978) 164-171
30. Snell R.G., MacMillan J.C., Cheadle J.P., Fenton I., Lazarou L.P., Davies P., et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genetics 4 (1993) 393-397
31. Soliveri P., Monza D., Piacentini S., Paridi D., Nespolo C., Gellera C., et al. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Neurological Science 23 Suppl. 2 (2002) S105-S106
32. SPSS Inc. SPSS Base 10.0 user's guide (1999), SPSS Inc., Chicago, IL
33. Squitieri F., Cannella M., Giallonardo P., Maglione V., Mariotti C., and Hayden M.R. Onset and pre-onset studies to define the Huntington's disease natural history. Brain Research Bulletin 56 (2001) 233-238
34. Tsuang D., Almqvist E.W., Lipe H., Strgar F., DiGiacomo L., Hoff D., et al. Familial aggregation of psychotic symptoms in Huntington's disease. American Journal of Psychiatry 157 (2000) 1955-1959
35. Warner J.P., Barron L.H., and Brock D.J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Molecular and Cellular Probes 7 (1993) 235-239
36. Weigell-Weber M., Schmid W., and Spiegel R. Psychiatric symptoms and CAG expansion in Huntington's disease. American Journal of Medical Genetics 67 (1996) 53-57
37. Zappacosta B., Monza D., Meoni C., Austoni L., Soliveri P., Gellera C., et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Archives of Neurology 53 (1996) 493-497